Sillaire-Houtmann, I <br/><br/>
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].  [electronic resource] 

 -  Journal francais d'ophtalmologie  Jan 2004 
 - 34-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0181-5512 
<br/><br/><label>Standard No.: </label>10.1016/s0181-5512(04)96089-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzamides<br/>Choroid Neoplasms--diagnosis<br/>Ciliary Body<br/>Conjunctival Neoplasms--diagnosis<br/>Diagnosis, Differential<br/>Eye Neoplasms--diagnosis<br/>Female<br/>Humans<br/>Iodine Radioisotopes<br/>Liver Neoplasms--diagnostic imaging<br/>Male<br/>Melanoma--diagnosis<br/>Ophthalmoscopy<br/>Predictive Value of Tests<br/>Radionuclide Imaging<br/>Radiopharmaceuticals<br/>Sensitivity and Specificity<br/>Skin Neoplasms--diagnostic imaging<br/>Tomography, X-Ray Computed<br/>Ultrasonography<br/>Uveal Neoplasms--diagnosis